A large observational study demonstrated that the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) after hospital discharge is associated with better outcomes in patients with AKI [28]. The gene discussed is ACE; the disease is acute kidney injury.